Trial intelligence / Profile preview

IPT with DP in Schoolchildren for Household Malaria Impact

NCT04660110Phase 3Unknown

Sponsor
Makerere University
Start
Jan 2021
Primary completion
Jun 2021
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Makerere University. Status: unknown.

02

Drugs

dihydroartemisinin + piperaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT04660110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04660110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call